IBDEI2VF ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45798,1,3,0)
 ;;=3^Adjustment & Management of VAD
 ;;^UTILITY(U,$J,358.3,45798,1,4,0)
 ;;=4^Z45.2
 ;;^UTILITY(U,$J,358.3,45798,2)
 ;;=^5062999
 ;;^UTILITY(U,$J,358.3,45799,0)
 ;;=Z76.0^^173^2283^18
 ;;^UTILITY(U,$J,358.3,45799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45799,1,3,0)
 ;;=3^Issue of Repeat Prescription
 ;;^UTILITY(U,$J,358.3,45799,1,4,0)
 ;;=4^Z76.0
 ;;^UTILITY(U,$J,358.3,45799,2)
 ;;=^5063297
 ;;^UTILITY(U,$J,358.3,45800,0)
 ;;=Z01.818^^173^2283^24
 ;;^UTILITY(U,$J,358.3,45800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45800,1,3,0)
 ;;=3^Pre-Op Call
 ;;^UTILITY(U,$J,358.3,45800,1,4,0)
 ;;=4^Z01.818
 ;;^UTILITY(U,$J,358.3,45800,2)
 ;;=^5062628
 ;;^UTILITY(U,$J,358.3,45801,0)
 ;;=Z51.81^^173^2283^25
 ;;^UTILITY(U,$J,358.3,45801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45801,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
 ;;^UTILITY(U,$J,358.3,45801,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,45801,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,45802,0)
 ;;=I10.^^173^2283^17
 ;;^UTILITY(U,$J,358.3,45802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45802,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,45802,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,45802,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,45803,0)
 ;;=Z79.01^^173^2283^19
 ;;^UTILITY(U,$J,358.3,45803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45803,1,3,0)
 ;;=3^Long Term (Current) Use of Anticoagulants
 ;;^UTILITY(U,$J,358.3,45803,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,45803,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,45804,0)
 ;;=R73.09^^173^2283^3
 ;;^UTILITY(U,$J,358.3,45804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45804,1,3,0)
 ;;=3^Abnormal Glucose
 ;;^UTILITY(U,$J,358.3,45804,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,45804,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,45805,0)
 ;;=R68.89^^173^2283^13
 ;;^UTILITY(U,$J,358.3,45805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45805,1,3,0)
 ;;=3^General Symptoms & Signs
 ;;^UTILITY(U,$J,358.3,45805,1,4,0)
 ;;=4^R68.89
 ;;^UTILITY(U,$J,358.3,45805,2)
 ;;=^5019557
 ;;^UTILITY(U,$J,358.3,45806,0)
 ;;=R79.89^^173^2283^1
 ;;^UTILITY(U,$J,358.3,45806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45806,1,3,0)
 ;;=3^Abnormal Findings of Blood Chemistry
 ;;^UTILITY(U,$J,358.3,45806,1,4,0)
 ;;=4^R79.89
 ;;^UTILITY(U,$J,358.3,45806,2)
 ;;=^5019593
 ;;^UTILITY(U,$J,358.3,45807,0)
 ;;=Z71.89^^173^2283^8
 ;;^UTILITY(U,$J,358.3,45807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45807,1,3,0)
 ;;=3^Counseling,Oth Specified
 ;;^UTILITY(U,$J,358.3,45807,1,4,0)
 ;;=4^Z71.89
 ;;^UTILITY(U,$J,358.3,45807,2)
 ;;=^5063253
 ;;^UTILITY(U,$J,358.3,45808,0)
 ;;=Z71.2^^173^2283^12
 ;;^UTILITY(U,$J,358.3,45808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45808,1,3,0)
 ;;=3^Explanation of Exam or Test Finding
 ;;^UTILITY(U,$J,358.3,45808,1,4,0)
 ;;=4^Z71.2
 ;;^UTILITY(U,$J,358.3,45808,2)
 ;;=^5063244
 ;;^UTILITY(U,$J,358.3,45809,0)
 ;;=Z86.51^^173^2283^20
 ;;^UTILITY(U,$J,358.3,45809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45809,1,3,0)
 ;;=3^Personal Hx of Combat & Operational Stress Reaction
 ;;^UTILITY(U,$J,358.3,45809,1,4,0)
 ;;=4^Z86.51
 ;;^UTILITY(U,$J,358.3,45809,2)
 ;;=^5063470
 ;;^UTILITY(U,$J,358.3,45810,0)
 ;;=Z76.89^^173^2283^14
 ;;^UTILITY(U,$J,358.3,45810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45810,1,3,0)
 ;;=3^Health Services in Other Specified Circumstances
